BUZZ-Adaptive Biotechnologies股价上涨,因3亿美元可转换债券发行规模扩大

路透中文
Jun 17
BUZZ-<a href="https://laohu8.com/S/ADPT">Adaptive Biotechnologies</a>股价上涨,因3亿美元可转换债券发行规模扩大

6月17日 - ** 周三开盘前,Adaptive Biotechnologies(ADPT.O)股价上涨0.5%,报17.30美元,因该公司筹集的资金超过原定计划

** 总部位于华盛顿州西雅图的ADPT宣布定价 (link),将通过私募发行3亿美元、2031年到期的0%可转换债券

** 发行规模从2.5亿美元上调;初始转换价格为24.11美元,较周二收盘价17.22美元溢价40%

** 公司计划将募集净额用于偿还奥博医疗(OrbiMed)的收购协议款项,并用于一般经营用途以及在微小残留病变(MRD)业务领域的机会性举措

** 周一晚间,ADPT (link) 公布了将其微小残留病变(MRD)和免疫医学业务分拆的计划,首席执行官兼联合创始人查德·罗宾斯(Chad Robins)表示,这是“释放两项业务全部潜能、增强其对患者的影响力并为股东创造长期价值的最佳途径”

** 周二,ADPT股价收跌1.4%,市值约为28亿美元。该股今年以来累计上涨6%,过去12个月累计上涨67%

** 据伦敦证券交易所集团(LSEG)数据显示,8位分析师的平均评级为“买入”,目标价中位数为20.50美元

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10